About Vironexis

Virus-powered medicine.
Get in touch

Our breakthrough, off-the-shelf technology could replace protein and CAR-T therapeutics.

Vironexis is a preclinical with early stage clinical opportunity company leveraging gene therapy to achieve sustained levels of protein therapeutics.

Our Mission

Our mission at Vironexis is to conduct preclinical development and early phase clinical trials of high, sustained and controllable protein therapeutics with a single shot.

Meet our team

Want to learn more?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
contact us now